Vivet Therapeutics is heading to Rome for the 2024 Cell & Gene Meeting on the Med from 9 – 11 April.
Come and listen to our CEO, @Jean-Philippe Combal on 9 April at 10am CEST, where he will deliver a presentation on hashtagVivet‘s diversified pipeline of hashtagrAAV based hashtaggenetherapies for rare inherited liver metabolic disorders including hashtagWilsonsDisease and hashtagCTX.
Jean-Philippe will also participate in a closing workshop panel on 10 April at 17.15 CEST, to discuss and provide insights on ‘Redefining the Global Regulatory Landscape for ATMP Commercial Approval – One Approval to Rule Them All’.
This leading conference is a must-attend event for anyone involved in the hashtagATMP community. Reach out if you would like to connect with our CEO to learn more about hashtagVivet and its patented technologies using the link in the first comment below!
